Allergan Says Breast Implant MDL Claims Are Preempted

By Mike Curley (August 10, 2020, 6:35 PM EDT) -- Allergan Inc. is urging a New Jersey federal court to throw out claims in multidistrict litigation alleging that it hid the health risks of its textured breast implants, saying that because the implants' design, manufacture and marketing were approved by the Food and Drug Administration, the claims are preempted by federal law....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!